Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk - Reply

被引:0
|
作者
Hermann, M. [1 ]
Ruschitzka, F. [1 ]
机构
[1] Univ Zurich Hosp, Dept Cardiol, CH-8091 Zurich, Switzerland
关键词
D O I
10.1111/j.1445-5994.2006.01257.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:798 / 798
页数:1
相关论文
共 50 条
  • [31] Cardiovascular safety of non-steroidal anti-inflammatory drugs revisited
    Walker, Chris
    Biasucci, Luigi M.
    POSTGRADUATE MEDICINE, 2018, 130 (01) : 55 - 71
  • [32] Renal and cardiovascular toxicity of non-steroidal anti-inflammatory drugs
    McGettigan P.
    Platona A.
    Henry D.A.
    InflammoPharmacology, 2000, 8 (1) : 1 - 18
  • [33] Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
    Meek, Inger L.
    van de laar, Mart A. F. J.
    Vonkeman, Harald E.
    PHARMACEUTICALS, 2010, 3 (07): : 2146 - 2162
  • [34] Review: Cardiovascular complications of non-steroidal anti-inflammatory drugs
    Fosslien, E
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (04): : 347 - 385
  • [35] Use of Non-Steroidal Anti-Inflammatory Drugs and Heart Failure Risk in the Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project
    Arfe, Andrea
    Kollhorst, Bianca
    Schink, Tania
    Garbe, Edeltraut
    Herings, Ron
    Straatman, Huub
    Schade, Rene
    Villa, Marco
    Lucchi, Silvia
    Nicotra, Federica
    Valkhoff, Vera
    Romio, Silvana
    Thiessard, Frantz
    Schuemie, Martijn
    Varas Lorenzo, Cristina
    Pariente, Antoine
    Sturkenboom, Miriam
    Zambon, Antonella
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 408 - 409
  • [37] Risk of myocardial infarction with non-steroidal anti-inflammatory drugs
    Dubreuil M
    Louie-Gao Q
    Peloquin CE
    中华物理医学与康复杂志, 2018, 40 (11) : 857 - 857
  • [38] NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) Use of non-steroidal anti-inflammatory drugs (NSAIDs) as immunomodulatory agents
    Fullerton, James N.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [39] Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism
    Biere-Rafi, Sara
    Di Nisio, Marcello
    Gerdes, Victor
    Porreca, Ettore
    Souverein, Patrick
    de Boer, Anthonius
    Buller, Harry
    Kamphuisen, Pieter
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (06) : 635 - 642
  • [40] Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs
    Stehlik, Paulina
    Rosella, Laura
    Henry, David
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (02) : 362 - 367